Demo Sign up Log In

Ligand Pharmaceuticals Inc (LGND)

R&D Expenses

$14.67M

Quarterly · Period ending: Jun 30, 2026 · USD

LGND R&D Expenses

Latest reported$14.67Mperiod endingJun 30, 2026

Latest reported$14.67Mperiod endingJun 30, 2026

LGND Quarterly R&D Expenses ($0.00 → $14.67M)

Quarterly R&D Expenses

High-resolution chart · PNG

LGND r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	13,191,000
Mar 31, 2001	12,405,000
Dec 31, 2000	12,807,000
Sep 30, 2000	13,229,000
Jun 30, 2000	12,766,000
Mar 31, 2000	12,498,000
Dec 31, 1999	14,600,000
Sep 30, 1999	15,700,000
Jun 30, 1999	14,600,000
Mar 31, 1999	14,500,000
Dec 31, 1998	21,500,000
Sep 30, 1998	17,000,000
Jun 30, 1998	17,300,000
Mar 31, 1998	14,900,000
Dec 31, 1997	21,000,000
Sep 30, 1997	18,000,000
Jun 30, 1997	16,700,000
Mar 31, 1997	16,600,000
Dec 31, 1996	17,300,000
Sep 30, 1996	15,000,000
Jun 30, 1996	14,800,000
Mar 31, 1996	12,300,000
Dec 31, 1995	13,300,000
Sep 30, 1995	12,100,000
Jun 30, 1995	0
Mar 31, 1995	7,000,000
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.